Abbot alumna inspires and educates through radio show
Episode #1780
|
July 30th, 2025
Decoding GLP-1
Listen
GLP-1 (glucagon-like peptide-1) treatments for weight loss have been gaining a lot of attention recently, especially with medications like Wegovy® (semaglutide) and Mounjaro® (tirzepatide). These treatments are part of a class of drugs originally designed to treat type 2 diabetes, but they've shown remarkable effects in promoting weight loss as well. Dave Knapp reveals how GLP-1’s are changing lives in broader, profound ways. He delves into the history, science, and accessibility challenges of these treatments, offering insight into the emotional and social realities of living with obesity. Through personal stories from the “On The Pen” community, he showcases real-life triumphs and struggles, illustrating the transformative potential of GLP-1 medications beyond just weight loss. His work has been featured in Fortune, Bloomberg, Yahoo Finance, and Business Insider, solidifying his role as a trusted advocate and storyteller in the space.
Guest Links
Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy
  • Related Episodes
  • Episode #1015
    Rob Barnett
    Energy Expert & Bloomberg Intelligence Senior Analyst
    “The Economists’ Diet: The Surprising Formula for Losing Weight and Keeping It Off”
    22 min - 01/17/18
    Play
  • Episode #1435
    Joshua DeTillio
    Author
    “Healthy You, Healthy Team, Healthy Company: How to Implement an Employee Wellness Program in Your Organization”
    25 min - 02/09/22
    Play
  • Episode #1181
    Adia Harvey Wingfield PhD
    Author & Professor of Sociology, Washington University in St. Louis
    “Flatlining: Race, Work, and Health Care in the New Economy.”
    25 min - 09/04/19
    Play
Featuring:
Episode #
00:00
00:00